Montane™ 20 PHA Premium, Montanox™ 60 PHA Premium and Montane™ 80 PPI, three ingredients developed and produced by Seppic, received an approval from CDE and now have a cDMF listing helping our pharma customers access the Chinese pharmaceutical market
As a supplier of specialty healthcare ingredients, Seppic offers high quality excipients adapted for three routes of administration: oral, topical, and injectables. Among them, the MONTANE™ range consists of sorbitan esters while the MONTANOX™ range of polysorbate esters can be used to target different applications with dedicated grades available at Seppic.
These ranges are the result of Seppic's expertise in manufacturing high purity excipients that are EXCiPACT and meet the highest European Good Manufacturing Practice standards. With its excipients, Seppic offers the highest level of safety and reliability to its customers worldwide.
China being the second largest pharmaceutical market worldwide, with a significant expected growth in the upcoming years. It’s an important achievement for Seppic to have been able to successfully register ten pharmaceutical products in China from oral, dermopharma and injectable ranges since 2020, including three in 2023.